Erschienen in:
15.06.2018 | Breast Oncology
Oncoplastic Surgery in Breast Cancer: Don’t Forget the Boost!
verfasst von:
Chirag Shah, MD, Zahraa Al-Hilli, MD, Graham Schwarz, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 9/2018
Einloggen, um Zugang zu erhalten
Excerpt
A growing focus on cosmetic outcomes for women undergoing breast-conserving therapy has emerged, spurring the development of oncoplastic/partial breast reconstruction surgical techniques. Oncoplastic techniques can be offered to a large number of patients and include a variety of procedures. Local breast tissue rearrangements such as glandular advancement or rotation flaps can be employed for smaller defects, whereas, mastopexy and reduction mammoplasty may be offered for larger resections and in patients with larger-volume breasts.
1 The goals of these techniques are multifold and include restoration of an aesthetic breast contour and optimization of breast symmetry, while enabling the surgeon to obtain generous margins during oncologic resection.
2‐
6 Furthermore, patients with macromastia or significant ptosis undergoing radiotherapy may benefit from both reduced toxicity and improved function through relief of symptomatic macromastia. Taken together, these benefits translate into improvements in breast-related quality of life in women with breast cancer. However, one of the challenges associated with the increased use of oncoplastic techniques is incorporating the tumor bed boost that often accompanies whole-breast irradiation (WBI) following breast-conserving surgery. As such, the questions that have emerged include (1) what is the role of tumor bed boost following breast-conserving surgery, and (2) how can oncoplastic surgery be integrated into a paradigm that includes tumor bed boosts? …
